GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (TSXV:CANB) » Definitions » Gross Profit

CanadaBis Capital (TSXV:CANB) Gross Profit : C$10.87 Mil (TTM As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is CanadaBis Capital Gross Profit?

CanadaBis Capital's gross profit for the three months ended in Jan. 2024 was C$2.06 Mil. CanadaBis Capital's gross profit for the trailing twelve months (TTM) ended in Jan. 2024 was C$10.87 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. CanadaBis Capital's gross profit for the three months ended in Jan. 2024 was C$2.06 Mil. CanadaBis Capital's Revenue for the three months ended in Jan. 2024 was C$4.31 Mil. Therefore, CanadaBis Capital's Gross Margin % for the quarter that ended in Jan. 2024 was 47.78%.

CanadaBis Capital had a gross margin of 47.78% for the quarter that ended in Jan. 2024 => Durable competitive advantage

During the past 8 years, the highest Gross Margin % of CanadaBis Capital was 53.03%. The lowest was 26.12%. And the median was 42.21%.


CanadaBis Capital Gross Profit Historical Data

The historical data trend for CanadaBis Capital's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital Gross Profit Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23
Gross Profit
Get a 7-Day Free Trial -0.05 1.16 2.52 5.57 11.78

CanadaBis Capital Quarterly Data
Mar19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.24 2.70 3.48 2.63 2.06

Competitive Comparison of CanadaBis Capital's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Gross Profit distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's Gross Profit falls into.



CanadaBis Capital Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

CanadaBis Capital's Gross Profit for the fiscal year that ended in Jul. 2023 is calculated as

Gross Profit (A: Jul. 2023 )=Revenue - Cost of Goods Sold
=22.222 - 10.438
=11.78

CanadaBis Capital's Gross Profit for the quarter that ended in Jan. 2024 is calculated as

Gross Profit (Q: Jan. 2024 )=Revenue - Cost of Goods Sold
=4.309 - 2.25
=2.06

Gross Profit for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$10.87 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

CanadaBis Capital's Gross Margin % for the quarter that ended in Jan. 2024 is calculated as

Gross Margin % (Q: Jan. 2024 )=Gross Profit (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=2.06 / 4.309
=47.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


CanadaBis Capital  (TSXV:CANB) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

CanadaBis Capital had a gross margin of 47.78% for the quarter that ended in Jan. 2024 => Durable competitive advantage


CanadaBis Capital Gross Profit Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital (TSXV:CANB) Business Description

Traded in Other Exchanges
Address
PO Box 850, Rocky Mountain House, AB, CAN, T4T 1A6
CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.
Executives
Garfield Richards Senior Officer

CanadaBis Capital (TSXV:CANB) Headlines

From GuruFocus